Scientists at Florida International University have developed a promising new compound that could slow the progression of Parkinson’s disease and protect against life-threatening lung injury by targeting a key process inside cells. The research centers on dynamin-related protein 1 (DRP1), which helps control how mitochondria—often described as the powerhouses of cells—divide and function. When DRP1 becomes overactive, it can lead to impaired mitochondrial function, inflammation, and cell damage linked to disease.
Continue Reading this article here
